Generalized Anxiety Disorder research hub
5 indexed studies · 4 currently recruiting
- recruitingPHASE2
A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder
This study is testing a new medicine called SYT-510 for people with Generalised Anxiety Disorder (GAD). It's a short study looking at how safe and effective a single dose of SYT-510 is compared to a dummy pill.
United Kingdom - recruitingNA
Trigeminal Nerve Stimulation in Treatment-resistant Generalized Anxiety Disorder: a Feasibility Study
This study is looking into a new treatment called trigeminal nerve stimulation (TNS) for people who have severe anxiety (Generalised Anxiety Disorder) that hasn't improved with other medicines. We want to see if TNS is safe and if it helps reduce anxiety symptoms.
Canada - not yet recruitingNA
Group Transdiagnostic Cognitive Behavioural Therapy for Intolerance of Uncertainty Versus Applied Relaxation
This study looks at a new type of group talking therapy called CBT-IU for people who find uncertainty very upsetting. It compares CBT-IU to another therapy, Applied Relaxation, to see if CBT-IU helps reduce anxiety and changes how people deal with uncertainty better.
United Kingdom - recruitingNA
Risk and Resiliency Factors in the RCMP: A Prospective Investigation
This study looks at mental health in Canadian police (RCMP) recruits. It aims to understand what helps or harms their mental well-being when facing stressful situations, with the goal of improving support for them and other emergency workers.
Canada - active not recruitingPHASE3
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
This study is testing a new medicine called MM120 for people with Generalised Anxiety Disorder (GAD). It compares MM120 to a dummy pill (placebo) to see if it helps reduce anxiety. The study involves one dose of the medicine followed by a longer monitoring period.
United States · Czechia · France